Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Galactofuranose-containing glycoconjugates in trypanosomatids

R M de Lederkremer1, W Colli

  • 1Departamento de Química Orgánica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Argentina.

Glycobiology
|September 1, 1995
PubMed
Summary

Galactofuranose, a sugar found in parasites but not mammals, triggers host antibodies. Understanding its pathways could lead to new treatments for parasitic diseases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Proteome-wide modulation of S-nitrosylation in Trypanosoma cruzi trypomastigotes upon interaction with the host extracellular matrix.

Journal of proteomics·2020
Same author

Where do we aspire to publish? A position paper on scientific communication in biochemistry and molecular biology.

Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica·2019
Same author

Prokineticin receptor identified by phage display is an entry receptor for Trypanosoma cruzi into mammalian cells.

Parasitology research·2014
Same author

Selection of binding targets in parasites using phage-display and aptamer libraries in vivo and in vitro.

Frontiers in immunology·2013
Same author

In vivo infection by Trypanosoma cruzi: the conserved FLY domain of the gp85/trans-sialidase family potentiates host infection.

Parasitology·2010
Same author

Trypanosoma cruzi strains, Tulahuen 2 and Y, besides the difference in resistance to oxidative stress, display differential glucose-6-phosphate and 6-phosphogluconate dehydrogenases activities.

Acta tropica·2007

Area of Science:

  • * Glycobiology and Parasitology
  • * Molecular and Cellular Biology

Background:

  • * Galactofuranose is a unique sugar moiety present in glycoconjugates of protozoan parasites like Trypanosoma cruzi and Leishmania species.
  • * It is found in structures such as glycoinositolphospholipid (GIPL) anchors, lipopeptidophosphoglycans (LPPG), and lipopeptidophosphoglycans (LPG), and also modifies high-mannose glycans.
  • * Unlike mammalian hosts, which lack galactofuranose in their glycoconjugates, its presence in parasites elicits a host immune response.

Purpose of the Study:

  • * To highlight the significance of galactofuranose in parasitic glycoconjugates.
  • * To emphasize the potential of galactofuranose as a target for diagnostics and therapeutics.
  • * To underscore the need for research into the metabolic pathways of galactofuranose.

Main Methods:

  • * Characterization of galactofuranose in parasitic glycoconjugates.
  • * Analysis of the structural linkage (beta 1-->3 to Man) and location (terminal or internal) of galactofuranose.
  • * Comparative analysis of glycoconjugate composition between parasites and mammalian hosts.

Main Results:

  • * Galactofuranose is confirmed in GIPL-anchor-like structures and oligosaccharide cores of parasites.
  • * The sugar is typically linked beta 1-->3 to mannose, either terminally or internally within oligosaccharides.
  • * Mammalian hosts do not naturally produce glycoconjugates containing galactofuranose, leading to antibody production against it.

Conclusions:

  • * The unique presence of galactofuranose in parasites offers a potential avenue for targeted interventions.
  • * Host antibodies against galactofuranose may be crucial for understanding disease pathogenesis and developing diagnostic tools.
  • * Elucidating the metabolic pathways of galactofuranose attachment/removal is critical for designing novel anti-parasitic drugs.

Related Experiment Videos